Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|April 15, 2024
Intrathecal Vector Delivery in Juvenile Rats via Lumbar Cistern InjectionAnthony Donsante, Shauna A Rasmussen, Judith L Fridovich-KeilJournal of Inherited Metabolic Disease|November 15, 2025
Pretreatment With a Selected Strain of Baker's Yeast, GY007, Prevents the Accumulation of Galactose Metabolites Following Dietary Galactose Exposure in a GALT-Null Rat Model of Classic GalactosemiaShauna A Rasmussen, Olivia S Garrett, Judith L Fridovich-KeilJournal of Inherited Metabolic Disease|September 4, 2020
A pilot study of neonatal GALT gene replacement using AAV9 dramatically lowers galactose metabolites in blood, liver, and brain and minimizes cataracts in GALT-null rat pupsShauna A Rasmussen, Jennifer M I Daenzer, Judith L Fridovich-KeilPlos One|July 20, 2022
DAB-quant: An open-source digital system for quantifying immunohistochemical staining with 3,3'-diaminobenzidine (DAB)Sneh Patel, Sara Fridovich-Keil, Shauna A Rasmussen, et al.Journal of Inherited Metabolic Disease|December 29, 2021
Neonatal GALT gene replacement offers metabolic and phenotypic correction through early adulthood in a rat model of classic galactosemiaJennifer M I Daenzer, Shauna A Rasmussen, Sneh Patel, et al.Journal of Molecular Signaling|April 21, 2016
Activator of G-protein Signaling 3 Controls Renal Epithelial Cell Survival and ERK5 ActivationShauna A Rasmussen, Michelle Kwon, Jeffrey D Pressly, et al.JIMD Reports|July 14, 2025
A Pilot Study of Bone Marrow Transplantation in a GALT-Null Rat Model of Classic GalactosemiaShauna A Rasmussen, Madelyn M Seemiller, Ingrid Smith, et al.Journal of Inherited Metabolic Disease|December 18, 2019
A galactose-1-phosphate uridylyltransferase-null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue-specific and longitudinal differences in galactose metabolismShauna A Rasmussen, Jennifer M I Daenzer, Jessica A MacWilliams, et al.Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
G-protein signaling modulator 1 deficiency accelerates cystic disease in an orthologous mouse model of autosomal dominant polycystic kidney diseaseMichelle Kwon, Tengis S Pavlov, Kandai Nozu, et al.Pageof 1